First Trust Ownership
| FBT Etf | USD 171.22 2.37 1.40% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
First |
First Etf Ownership Analysis
First Trust is is formed as Regulated Investment Company in the United States. ETF is managed and operated by The Bank of New York Mellon Corporation. The fund has 31 constituents with avarage daily trading value of 35.4 K. The fund charges 0.4 percent management fee with a total expences of 0.56 percent of total asset. The fund retains 99.95% of assets under management (AUM) in equities. The fund will normally invest at least 90 percent of its net assets in the common stocks and depositary receipts that comprise the index. Biotechnology Index is traded on NYSEARCA Exchange in the United States. To learn more about First Trust NYSE call the company at NA.Investment Allocations (%)
Top Etf Constituents
| BIIB | Biogen Inc | Stock | |
| SGEN | Seagen Inc | Stock | |
| ALKS | Alkermes Plc | Stock | |
| EXAS | EXACT Sciences | Stock | |
| BMRN | Biomarin Pharmaceutical | Stock | |
| FGEN | FibroGen | Stock | |
| CRL | Charles River Laboratories | Stock | |
| AGIO | Agios Pharm | Stock | |
| ACAD | ACADIA Pharmaceuticals | Stock | |
| VRTX | Vertex Pharmaceuticals | Stock | |
| UTHR | United Therapeutics | Stock | |
| SRPT | Sarepta Therapeutics | Stock | |
| INCY | Incyte | Stock | |
| ILMN | Illumina | Stock | |
| NKTR | Nektar Therapeutics | Stock | |
| ALNY | Alnylam Pharmaceuticals | Stock | |
| GILD | Gilead Sciences | Stock | |
| MRNA | Moderna | Stock | |
| TECH | Bio Techne Corp | Stock | |
| REGN | Regeneron Pharmaceuticals | Stock | |
| NBIX | Neurocrine Biosciences | Stock | |
| AMGN | Amgen Inc | Stock | |
| MYGN | Myriad Genetics | Stock | |
| IONS | Ionis Pharmaceuticals | Stock |
Institutional Etf Holders for First Trust
| FBT | First Trust NYSE | Etf | |
| QAISX | Q3 All Weather Sector | Mutual Fund | |
| FVC | First Trust Dorsey | Etf | |
| FV | First Trust Dorsey | Etf | |
| DALI | First Trust Dorsey | Etf |
First Trust Outstanding Bonds
First Trust issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. First Trust NYSE uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most First bonds can be classified according to their maturity, which is the date when First Trust NYSE has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| FIRST UN P Corp BondUS337358BA27 | View | |
| FIRST UN P Corp BondUS337358BD65 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US337358BH79 Corp BondUS337358BH79 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in First Trust NYSE. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
The market value of First Trust NYSE is measured differently than its book value, which is the value of First that is recorded on the company's balance sheet. Investors also form their own opinion of First Trust's value that differs from its market value or its book value, called intrinsic value, which is First Trust's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because First Trust's market value can be influenced by many factors that don't directly affect First Trust's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between First Trust's value and its price as these two are different measures arrived at by different means. Investors typically determine if First Trust is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, First Trust's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.